Extracellular Vesicles From IFN-γ-Primed Mesenchymal Stem Cells Repress Atopic Dermatitis In Mice
December 2022
in “
Journal of Nanobiotechnology
”
Studysummary In this study, IFN-γ-stimulated iPSC-derived mesenchymal stem cell extracellular vesicles improved atopic dermatitis in mice by reducing Th2 cytokine activity, suppressing inflammation, and restoring skin barrier function, as evidenced by decreased itching and inflammatory markers.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer